Article (Scientific journals)
Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study
Vergès, B.; Boureille, F.; Goudet, P. et al.
2002In Journal of Clinical Endocrinology and Metabolism, 87 (2), p. 457-465
Peer Reviewed verified by ORBi
 

Files


Full Text
Pituitary disease in MEN type 1 (MEN1) - Data from the France-Belgium MEN1 multicenter study.pdf
Publisher postprint (1.33 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Secretory tumor; Parathyroid diseases; Benign neoplasm; Endocrinopathy; Europe; Neuroendocrine tumor; Gene; Genetics; Diagnosis; Comparative study; Belgium; France; Human; Adrenocorticotropic hormone; Female; Age of onset; Multicenter study; Prolactinoma; Somatotropin hormone; Hyperparathyroidism; Adenoma; Pituitary diseases; Tumeur sécrétante; Parathyroïde pathologie; Tumeur bénigne; Endocrinopathie; Tumeur neuroendocrinienne; Gène; Génétique; Diagnostic; Etude comparative; Belgique; Homme; ACTH; Femelle; Age apparition; Etude multicentrique; Prolactinome; STH; Hyperparathyroïdie; Adénome; Hypophyse pathologie
Abstract :
[en] To date, data on pituitary adenomas in MEN type 1 (MEN1) still have to be evaluated. We analyzed the data of a large series of 324 MEN1 patients from a French and Belgian multicenter study. Data on pituitary disease were compared with those from 110 non-MEN1 patients with pituitary adenomas, matched for age, year of diagnosis, and follow-up period. Genetic analysis of the MEN1 gene was performed in 197 of the MEN1 patients. In our MEN1 series, pituitary disease occurred in 136 of 324 (42%), less frequently than hyperparathyroidism (95%, P < 0.001) and endocrine enteropancreatic tumors (54%, P < 0.01). Mean age of onset of pituitary tumors was 38.0 +/- 15.3 yr (range, 12-83 yr). Pituitary disease was associated with hyperparathyroidism in 90%. of cases, with enteropancreatic tumors in 47%, with adrenal tumors in 16%, and with thoracic neuroendocrine tumors in 4%. Pituitary disease was the initial lesion of MEN1 in 17% of all MEN1 patients. MEN1 pituitary adenomas were significantly more frequent in women than in men (50% vs. 31%,P < 0.001). Among the 136 pituitary adenomas, there were 85 prolactinomas and 12 GH-secreting, 6 ACTH-secreting, 13 cosecreting, and 20 nonsecreting tumors. Eighty-five percent of MEN1-related pituitary lesions were macroadenomas (vs. 42% in non-MEN1 patients, P < 0.001), including 32% of invasive cases. Among secreting adenomas, hormonal hypersecretion was normalized, after treatment, in only 42% (vs. 90% in non-MEN1 patients, P < 0.001), with a median follow-up of 11.4 yr. No correlation was found between the type of MEN1 germ-line mutation and the presence or absence of pituitary adenoma. Our study, based on a large group of MEN1 patients, shows that pituitary adenomas occur in 42% of the cases and are characterized by a larger size and a more aggressive presentation than without MEN1.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Vergès, B.
Boureille, F.
Goudet, P.
Murat, A.
Beckers, Albert ;  Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Sassolas, G.
Cougard, P.
Chambe, B.
Montvernay, C.
Calender, A.
Language :
English
Title :
Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study
Publication date :
February 2002
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Volume :
87
Issue :
2
Pages :
457-465
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Cet article a bénéficié d'un éditorial de : S.J. Marx - NIH Bethesda, Maryland. Agressive Pituitary Tumors in MEN1 : Do they refuse the Two-Hit Model of Tumorigenesis ? Editorial publié dans J.Clin.Endocrinol.Metab, vol 87 ; n°2 February 2002 : 453-456.
Available on ORBi :
since 18 March 2010

Statistics


Number of views
405 (6 by ULiège)
Number of downloads
650 (5 by ULiège)

Scopus citations®
 
399
Scopus citations®
without self-citations
334
OpenCitations
 
98

Bibliography


Similar publications



Contact ORBi